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Abstract
Increases in longevity resulting from improvements in health care and living conditions together
with a decrease in fertility rates have contributed to a shift towards an aged population profile. For
the first time the UK has more people over age 60 than below 16 years of age. The increase in
longevity has not been accompanied by an increase in disease-free life expectancy and research into
ageing is required to improve the health and quality of life of older people. However, as the House
of Lords reported, ageing research in the UK is not adequately structured and a clear vision and
plan are urgently required. Hence, with the aim of setting a common vision for action in ageing
research in the UK, a 'Spark Workshop' was organised. International experts from different
disciplines related to ageing research gathered to share their perspectives and to evaluate the
present status of ageing research in the UK. A detailed assessment of potential improvements was
conducted and the prospective secondary gains were considered, which were subsequently
distilled into a list of 'ten commandments'. We believe that these commandments, if followed, will
help to bring about the necessary implementation of an action plan for ageing research in the UK,
commensurate with the scale of the challenge, which is to transform the manifold opportunities of
increased longevity into actual delivery of a society living not only for longer, but also healthier,
wealthier and happier.
Why ageing research?
Our society is experiencing unprecedented demographic
change [1]. Improvements in health care and living condi-
tions together with a decrease in fertility rates, have con-
tributed to the ageing of the population and a severe
demographic redistribution [1,2]. According to the
national census of 2001, for the first time in the UK there
are more people over age 60 years than under age 16 years
[3]. However, a large proportion of people over age 60
suffer from chronic illnesses or disabilities [3,4]. In con-
Published: 3 May 2007
BMC Geriatrics 2007, 7:10 doi:10.1186/1471-2318-7-10
Received: 12 February 2007
Accepted: 3 May 2007
This article is available from: http://www.biomedcentral.com/1471-2318/7/10
© 2007 Franco et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7
(page number not for citation purposes)
BMC Geriatrics 2007, 7:10 http://www.biomedcentral.com/1471-2318/7/10trast to the UK, in some other countries (e.g. Japan) it has
been found that extended lifespan does not necessarily
translate into increased morbidity [3,4].
Coping with the impacts of these demographic changes is
one of the greatest challenges for the 21st century. How-
ever, ageing research in the UK is largely fragmented,
underrepresented, poorly coordinated and lacks adequate
funding support. In 2005, The House of Lords Select
Committee on Science and Technology undertook an
inquiry, chaired by Lord Sutherland of Houndwood, to
evaluate the scientific aspects and current situation of age-
ing research in the UK. Among other findings, the inquiry
reported "the attempts at coordination so far made under
the aegis of the research councils are woefully inadequate.
The image we have is of a series of ill-thought-out initia-
tives which have long titles, short lives, vague terms of ref-
erence, little infrastructure, and no sense of purpose. A
radical reorganisation is essential" [5]. This inadequacy
identified by the enquiry and the current demographic
changes were the primary incentives for convening a
'Spark Workshop' -a two-day meeting, in which research-
ers from different areas across industry, charities, govern-
ment and academia, share knowledge, explore potential
novel concepts, and assess possibilities for future activi-
ties. The aims of the workshop were (i) to evaluate the
future of ageing research in the UK, and (ii) to formulate
a vision for action.
The workshop, held in May 2006, was jointly convened by
the Funders' Forum for Research on Ageing and Older
People (FFRAOP, or Funders' Forum) – a multi-agency
alliance with a remit of coordinating ageing research in
the UK- and the Corporate Research division of Unilever -
a multinational foods, home and personal care company
with a longstanding interest in promoting healthy ageing.
What is ageing and ageing research?
Ageing is not a disease; it is a multi-factorial process that
can be defined as the progressive loss of function accom-
panied by increasing morbidity and decreasing fertility
with advancing age [6]. However, ageing is often per-
ceived clinically as a collection of diseases [7]. Confusion
about the precise nature of the relation between ageing
and disease is a longstanding issue that has impeded the
necessary progress towards the understanding of the
intrinsic ageing process [7]. Ageing research must be inde-
pendently recognized and funded to gain a clear under-
standing of the mechanisms that provoke the preceding
vulnerability to the development of age-related disorders.
Ageing research can be classified into different areas: (i)
the mechanisms of ageing, (ii) the socio-economic factors
of ageing, (iii) research aimed to achieve healthy ageing in
humans and (iv) research on age-related disorders (Figure
1). All must be considered and supported, in order to
achieve effective ways to arrive at best-practice routes to
extend healthy life expectancy. But at present there is an
important imbalance in the amount of resources destined
to subsidise research initiatives associated with age-
related disorders rather than funding all the areas of age-
ing research, particularly healthy ageing.
What is the situation of ageing research in the 
UK?
In the UK the research emphasis on end-point disease has
lead to a situation where relatively few resources are allo-
cated to support ageing research [5]. In the recently pub-
lished UK Health Research analysis -an effort to map the
current UK research portfolio- ageing research is not sepa-
rately identified [8]. Moreover, research in prevention -
including preventable age-related disorders- comprises no
more that 2.5% of all health-related research (Figure 2)
[8].
Not only are resources limited, but there is also a grave
lack of the coordination and direction needed to scope
and secure the missing funds [5]. After a not very success-
ful attempt by the National Collaboration on Ageing
Research (NCAR) established in 2001 and dismantled in
2005, the Funders' Forum (FFRAOP) is currently the sole
organization with the role of representing and coordinat-
ing British ageing research [5]. To compound matters, the
Forum is not mandated to direct research, has no dedi-
cated corporate budget and has to proceed on the basis of
consensus between its members.
Longevity: cost or gain?
Throughout the 19th and 20th centuries, the UK has expe-
rienced a sustainable increase in longevity, which is still
ongoing. Although few would argue that the postpone-
ment of death is a tangible gain, the value of increasing
longevity is difficult to translate into monetary terms, and
there has often been an undue focus on the perceived neg-
atives (health and social care costs, including pensions).
However, using individual's willingness to pay for
improvements that statistically extend life expectancy,
Murphy and Topel have devised a framework for valuing
the gains in health and longevity that allows calculating
the economic gains from past, present and prospective
future improvements in longevity and mortality rates [9].
When applied to the situation seen in the United States
during the 20th century, the authors found that the overall
economic gains of increased longevity are enormous.
Gains in life expectancy over the century were worth over
$1.2 million per person to the current US population.
From 1970 to 2000, gains in life expectancy added about
$3.2 trillion per year to national wealth. In the UK these
numbers can be expected to be proportionally similar as
the longevity gains have been comparable [1]. It may bePage 2 of 7
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directly translate into economic gains for individuals and
society as a whole. As research-led advances in biomedi-
cine are an important source of gains in longevity, invest-
ments in research on ageing should properly be seen
within the context of their potentially enormous societal
returns.
Increased ageing society = increased 
productivity?
Increased longevity, if accompanied by increased health
span, may mean that significant numbers of the labour
force reaching a fixed retirement age will still have a full or
considerable capacity for production. Furthermore, it has
been found that age of retirement has a significant influ-
ence in remaining life expectancy [10]. Tsai SP et al
reported an improvement of mortality with increasing age
at retirement independent of socioeconomic status. Life
expectancy for those retiring at age 55 was found to be 5
years shorter compared to those that retired at age 65 [10].
However, further research is necessary to identify the fac-
tors and mechanisms associated with an increased life
expectancy after late retirement.
It is well known that work appears to be an important part
of an individual's life providing a role and status in society
and structure to the daily routine. These findings support
current initiatives from different institutions and govern-
ments promoting policy changes to increase the current
age of retirement. Thus, if ageing research can deliver
healthier, longer lives, it can also deliver increased wealth
by permitting extended social and economic productivity.
Science of ageing: should it be multidisciplinary?
Ageing is a complex process influencing multiple mecha-
nisms and physiological systems. Therefore it is critical
Areas of ageing researchFigure 1
Areas of ageing research. Abbreviations: FOAD, Fetal Origins of Adult Disease.
Human Healthy Ageing
•FOAD
•Epidemiology
•Genes & Environment
•Understanding reversibility
•Interventions
•Personal vs. population
Mechanisms
•Aetiology
•Allostasis
•Biomarkers
•Genetics
•Systems
•Models
Socio-Economic
•Value of Healthy Ageing
•Life course transitions
•Autonomy & Purpose
•Healthy Behaviours
•Health Services
•Emotional well-being
•Assisted Technologies
Age-Related Disorders
•Cancer
•Respiratory diseases
•Cardiovascular disease
•Neurodegenerative disorders
•Musculoskeletal diseases
•Sensorial dysfunction
•End of life care 
•Geriatric care
Translation into best practicePage 3 of 7
(page number not for citation purposes)
BMC Geriatrics 2007, 7:10 http://www.biomedcentral.com/1471-2318/7/10that ageing research involves multidisciplinary research
teams following a complementary approach. Further-
more, ageing has to be contextualised in terms of the
social, economic and physical environments in which it
takes place. New research initiatives in the ageing field
could help to identify factors that characterise individuals
that reach very old ages in good health. In this context it is
particularly important to define and identify the 'healthy
phenotype' as well as detect early deviations from this
state, in order to permit intervention when a condition is
still reversible. These factors can be of different order,
including environmental, social, lifestyle and genetic fac-
tors; and they act together at different levels: intrinsically
and extrinsically, to modify the human life course. Much
remains unknown about how intrinsic and extrinsic fac-
tors interact to affect longevity and the way these mecha-
nisms might be influenced to reach the ultimate goal of
ageing research: increase quality and length of life.
Is age-related disease reversible (the example of 
CVD)?
Cardiovascular disease (CVD) prevention is particularly
important in preventing age-related morbidities. Ageing
has been shown to affect the structure of the arterial wall
allowing for infiltration and retention of oxidised lipids
with associated chronic inflammation [11-13]. However,
this is not an inevitable process; it is likely that age-associ-
ated arterial changes can be attenuated or delayed. Certain
lifestyle modifications and medications have shown a
potential reversibility of the age-related arterial changes
that lead to CVD [11,13,14]. But, whether early attenua-
tion of pathological arterial ageing will prevent or delay
Proportion of combined research activity, Kite diagram*Figure 2
Proportion of combined research activity, Kite diagram*. *Source: UK Clinical Research Collaboration. UK Health 
Research Analysis. 2006 Available from: http://www.ukcrc.org/PDF/UKCRC_Health_Research_Analysis_Report.pdfPage 4 of 7
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efforts on ageing research should focus on identifying the
factors and mechanisms that could affect retardation and
perhaps reversal of the early pathological process, as well
as effective interventions to positively modify these factors
and prevent or delay CVD.
Can we beat cognitive decline?
Ageing is also related to progressive cognitive decline [15-
17]. However, as with arterial ageing, severe cognitive
decline does not appear to be an inevitable process [15-
17]. Alzheimer disease (AD), one of the most relevant and
frequent causes of cognitive decline, is only genetically
determined to a small extent, and modifiable environ-
mental and lifestyle factors (e.g. smoking, nutrition, phys-
ical inactivity and low social activity) are thought to play
a key role in its development [15-17]. New research
should aim to identify the factors linked with cognitive
decline and to clarify the ways environment and genes
interact to foment neurological deterioration.
Is there a way to change our disabling 
environments?
Besides CVD and cognitive decline, arthritis and sensorial
dysfunction are conditions that although not related with
a large mortality impact, are highly related with ageing
and amply affect the capacity of the elderly population to
interact with their surrounding environment. Due to the
high prevalence of these limiting conditions among the
elderly and to the fact that many of them are less
acquainted with the state of the art in technology, elderly
populations find it particularly challenging to keep up
with the latest technological advances. It is fundamental
for today's society to consider the needs and limitations of
a progressively growing elderly population in the genera-
tion and design of new technology. To this end it is vital
to create an environment where elderly individuals are
empowered to live independently as well as to interact
and communicate with a minimum level of limitation.
Information technology, assistive technology and inclu-
sive design are all essential tools to facilitate a society fit
for older people [18,19]. These disciplines can effectively
minimise the technological impact and limitations
imposed by progressive developments by more fully
involving functionally-limited older people in the
research process [18-20]. These tools however, are not
commonly implemented in the construction and design
of products, homes, urban environment, public buildings
and transportation systems. Increasing the funds for tech-
nology research on health, social and housing services,
and involving the elderly in the design and production
processes, will aid to eliminate disabling environments
for disabled people.
What defines quality of life for older people?
Ageing research should focus on aiding populations not
only to live longer but also healthier and at a satisfactory
level of quality of life (QoL) [21,22]. Quality of life
requires a multidimensional parameter evaluation, using
both intrapersonal and social-normative criteria, and tak-
ing account of an individual in time (past, current and
anticipated). Great differences exist at inter- and intra-per-
sonal levels in the assessment of QoL. Influential variables
on QoL include: marital status, income, health status and
social environment [22]. Designing and implementing
interventions to positively modify some of these factors
may guarantee a better quality of life for the elderly by for
example facilitating social participation, supporting social
networks, employing older workers and taking strong
actions to eradicate ageism [22].
On the other hand, QoL may act as a predictor per se of
age-related disorders (e.g. CVD, AD), but research in this
area is scattered and scarce. To clarify potential mecha-
nisms involved in healthy ageing it is critical to discern the
effect of QoL in longevity, morbidity and vice versa.
Genetics of longevity: eating for a longer life?
Many epidemiological studies have found significant
associations between diet quality and prevention of
chronic disease and mortality [23]. Paradoxically, some
nutrition intervention studies have failed to show benefits
for ingredients (as opposed to foods) -e.g. anti-oxidant
vitamins- for which, based on cellular studies in vivo, ben-
efits had been expected [24,25]. It is clear that effects of
putative agents differ by gender and ethnicity confirming
a potential influence of genetic factors. For instance, sev-
eral lipid candidate genes that have been explored in
terms of CVD risk and longevity have shown significant
gene-diet-environment interactions [26,27]. Hence,
genetics is a key tool for future studies of mechanisms of
age-related conditions. However, most of the studies in
this area have been limited by their design (i.e. cross-sec-
tional design, small sample size, limited SNP (Single
Nucleotide Polymorphism) coverage of small candidate
genes, and poor accountability of environmental factors).
To benefit fully from the contribution of genetics, large
prospective studies need to be designed, fully supported
by extensive genotyping and analytical capacities. Further-
more, reliable intermediate phenotypes for ageing are
urgently needed, both for genetic studies and for potential
interventions.
How to make it happen?
The 10 commandments for ageing research in the UK
It is urgent that the UK adopts an integrated, multidiscipli-
nary approach to ageing research, which recognizes its
great importance as a societal and governmental priority.
As it is identified in the House of Lords' report, the sciencePage 5 of 7
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poorly coordinated. Since the 'ownership' of ageing sci-
ence in the U.K. is at present dispersed and ambiguous, it
is essential to re-structure and organize ageing research
under a clear representation that could secure the funds
needed to guarantee its full development. The efforts
made for instance in Canada in the last few years, suggest
that the creation of a 'virtual' ageing institute may contrib-
ute to create a stronger ownership and focus on ageing
research, facilitate a multi-disciplinary approach to ageing
science and assist young scientists to identify and develop
career opportunities in the field. However, independent
to the model adopted, it is evident that ageing research in
the UK urgently requires a clearly defined organisational
structure to guarantee its successful implementation and
the realisation of its main goal: a population living longer,
healthier and happier.
These and other conclusions reached during this 'Spark
Workshop' have been summarized in a list of ten points,
which constitute the backbone of a vision for action that
could help to guarantee the successful implementation of
ageing research in the UK:
1. Ageing is a highly differentiated and malleable process.
Therefore, the commitment must be to develop interven-
tions that can affect the ageing process or the experience
of ageing in order to extend healthy life expectancy, inde-
pendence and well-being in old age.
2. Investments in ageing research should be significantly
increased as they are likely to produce immense gains to
both the economy and society, in particular to the quality
of life, productivity and self-sufficiency of the rapidly
growing older population group
3. Society must recognise that improving the quality of life
(QOL), of older people, including the promotion of active
ageing and the eradication of ageism, is one of the biggest
challenges of the 21st century. This should translate into
an integrated governmental policy for research on ageing
as a key driver of QOL improvements.
4. Ageing research should reflect the complexity of the
ageing process and integrate different dimensions of
research into human healthy ageing, including the biolog-
ical mechanisms and the socio-economic, cultural and
psychological determinants of the ageing process
5. Healthy ageing research should concentrate on early,
reversible stages of pathological conditions. As many life-
style-related chronic diseases share common pathways of
early dysregulation (e.g. CVD, AD), the development of
markers, diagnostic techniques and interventions that can
be applied to prevent late stage disease is fundamental
6. Ageing research should build on and expand existing
longitudinal cohorts. These are critical to understand lon-
gevity and must combine genetic, socio-demographic and
environmental aspects. It is crucial that future efforts
embrace the role of genetics in ageing research given the
variability of responses of individuals to drugs, nutrients
and lifestyles due to different polymorphisms
7. Ageing research should pursue 'best practice' early inter-
ventions by creating an evidence base for translation to
society, by engaging directly with its end users and, in par-
ticular, by ensuring that older people are a key reference
point.
8. Research to inform the development and uptake of
information technology, assistive technology and inclu-
sive design must be implemented in the construction and
design of products, homes, urban environments, public
buildings and transportation systems to eradicate poten-
tially disabling environments to functionally-limited
older populations
9. The void in clear leadership, funding and representa-
tion of ageing research in the UK must be addressed. In
particular, additional resources must be allocated to
under-funded areas of ageing research (e.g. healthy age-
ing) to complement existing commitments to research
aimed towards end-point chronic disease
10. It is critical that an overall ageing research portfolio is
managed as a single entity across the contributing disci-
plines, which individually and collectively enhance
understanding about the determinants and interventions
that affect active ageing.
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